Neurocrine Biosciences Financials

Values in thousands	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Revenue	$687,500	$572,600	$627,700	$622,100
Gross Profit	676,200	563,400	618,400	614,100
EBITDA	152,900	31,300	181,700	191,300
EBIT	145,600	23,700	174,600	184,800
Net Income	107,500	7,900	103,100	129,800
Net Change In Cash	687,500	572,600	627,700	622,100
Free Cash Flow	89,500	54,100	235,200	149,900
Cash	264,000	194,100	233,000	349,100
Basic Shares	101,000	102,500	102,900	104,300

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,355,300	$1,887,100	$1,488,700	$1,133,500
Gross Profit	2,321,300	1,847,400	1,465,500	1,119,200
EBITDA	639,700	416,100	264,600	138,100
EBIT	612,600	394,800	249,000	127,200
Net Income	341,300	249,700	154,500	89,600
Net Change In Cash	2,355,300	1,887,100	1,488,700	1,133,500
Cost of Revenue			-72,000	153,700
Free Cash Flow	557,200	361,600	322,900	233,100
Cash	233,000	251,100	262,900	340,800
Basic Shares	103,700	101,000	98,900	97,900